EUVIMEDEUVIMED entdecken
Kohortenstudie

Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study

L. Fritz

Zeitschrift für Gastroenterologie · 01.05.2024 · 62 (05) · e480

DOI: 10.1055/s-0044-1786887 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2024. Verfasst von L. Fritz.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims: Steatotic liver disease (SLD) has become the most prevalent liver disease. Non-invasive methods for assessing liver fibrosis and predicting liver-related complications, such as liver stiffness measurement (LSM), need to be investigated and validated for SLD. Therefore, we studied changes in LSM and their ability to predict hepatic decompensation in SLD patients.

Methods

This retrospective study was conducted at the Medical University of Vienna, involving 540 patients with metabolic dysfunction-related steatotic liver disease or alcohol-related (steatotic) liver disease. Patients were included if they had at least two reliable LSMs taken≥180 days apart and were categorized according to their liver disease severity: non-advanced chronic liver disease (non-ACLD), compensated ACLD (cACLD) and decompensated ACLD (dACLD). The difference between the first (Baseline-LSM) and second reliable LSM (Updated-LSM) was calculated to assess changes in LSM.

Results

299 patients (55.4%) showed any decrease in LSM while 208 patients (38.5%) showed a decrease of≥20%. Changes in LSM were more pronounced in cACLD (n=148, 27.4%) and dACLD (n=58, 10.7%). During a median follow-up time of 54.4 months, 59 patients (10.9%) experienced hepatic decompensation in the overall cohort (30 with cACLD (18.3%) and 27 with dACLD (46.6%)). Baseline-LSM (AUROC: 0.861 [CI95%, 0.774-0.947]) and Updated-LSM (AUROC: 0.895 [CI95%, 0.814-0.976]) were numerically more accurate in predicting hepatic decompensation within 24 months compared to laboratory parameters. The Baveno VII criteria for a clinically significant decrease in LSM distinguished the high- from the low-risk subgroup (cumulative incidence at 24 months: 1.1% vs. 22.0%, hazard ratio: 8.49 (CI95%, 3.07-23.46; p

Zitieren

APA

Fritz, L. (2024). Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study. Zeitschrift für Gastroenterologie, 62(05), e480. https://doi.org/10.1055/s-0044-1786887

Vancouver

Fritz L. Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study. Zeitschrift für Gastroenterologie. 2024;62(05):e480. doi:10.1055/s-0044-1786887

BibTeX
@article{Fritz2024,
  author = {Fritz, L.},
  title = {Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {05},
  pages = {e480},
  doi = {10.1055/s-0044-1786887}
}
Kostenlos starten →